A screening and prevention programme serving an ethnically diverse population of women at high risk of developing breast and/or ovarian cancer

Abstract

Introduction

Current Genetic Service Delivery Models for the Provision of Genetic Testing in Europe: A Systematic Review of the Literature

“…Non-medical HCPs involved in patient referrals included nurses (Byck et al, 2006; Bennett et al, 2007; Drury et al, 2007; Eeles et al, 2007; Orlando et al, 2013; Long and Goldblatt, 2014; Shepherd et al, 2014; Vickery et al, 2014), genetic coordinators of local health departments and genetic counselors in regional genetic centers (Bickerstaff et al, 2001; Byck et al, 2006; Coffey et al, 2008), and midwives (Byck et al, 2006; Hamblion et al, 2012). Referrals to genetic services were also made by different categories of HCP engaged in population screening programs, such as prenatal and newborn screening (Table 3); hereditary breast and ovarian cancer (HBOC) screening (Washington State Department of Health, 2008; Little et al, 2009; Smith et al, 2009; Evans et al, 2012); colorectal cancer screening (Little et al, 2009; Schofield et al, 2009, 2014); population-based screening of Ashkenazi Jews (i.e., Tay-Sachs, CF, Fanconi anemia type C, Canavan disease, Gaucher type I) (Bach et al, 2001; Ekstein and Katzenstein, 2001; Barlow-Stewart et al, 2003; Kornreich et al, 2004; Gason et al, 2005; Washington State Department of Health, 2008); screening of Mediterranean and North African populations (i.e., beta-thalassemia, sickle cell) (Lena-Russo et al, 2002; Amato et al, 2014); and familial hypercholesterolemia (FH) (Aarden et al, 2011).…”